Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Farré López, Núriaca
- dc.contributor.author Lupón, Josepca
- dc.contributor.author Roig, Eulàliaca
- dc.contributor.author Gonzalez-Costello, Joseca
- dc.contributor.author Vila, Joanca
- dc.contributor.author Pérez, Silviaca
- dc.contributor.author De Antonio Cuscó, Martaca
- dc.contributor.author Solé-González, Eduardca
- dc.contributor.author Sánchez-Enrique, Cristinaca
- dc.contributor.author Moliner Borja, Pedroca
- dc.contributor.author Ruiz-Bustillo, Soniaca
- dc.contributor.author Enjuanes Grau, Cristinaca
- dc.contributor.author Mirabet, Soniaca
- dc.contributor.author Bayes-Genis, Antonica
- dc.contributor.author Comín Colet, Josepca
- dc.contributor.author GICCAT investigatorsca
- dc.date.accessioned 2018-10-19T07:17:16Z
- dc.date.available 2018-10-19T07:17:16Z
- dc.date.issued 2017
- dc.description.abstract OBJECTIVES: The aim of this study was to analyse baseline characteristics and outcome of patients with heart failure and mid-range left ventricular ejection fraction (HFmrEF, left ventricular ejection fraction (LVEF) 40%-49%) and the effect of 1-year change in LVEF in this group. SETTING: Multicentre prospective observational study of ambulatory patients with HF followed up at four university hospitals with dedicated HF units. PARTICIPANTS: Fourteen per cent (n=504) of the 3580 patients included had HFmrEF. INTERVENTIONS: Baseline characteristics, 1-year LVEF and outcomes were collected. All-cause death, HF hospitalisation and the composite end-point were the primary outcomes. RESULTS: Median follow-up was 3.66 (1.69-6.04) years. All-cause death, HF hospitalisation and the composite end-point were 47%, 35% and 59%, respectively. Outcomes were worse in HF with preserved ejection fraction (HFpEF) (LVEF>50%), without differences between HF with reduced ejection fraction (HFrEF) (LVEF<40%) and HFmrEF (all-cause mortality 52.6% vs 45.8% and 43.8%, respectively, P=0.001). After multivariable Cox regression analyses, no differences in all-cause death and the composite end-point were seen between the three groups. HF hospitalisation and cardiovascular death were not statistically different between patients with HFmrEF and HFrEF. At 1-year follow-up, 62% of patients with HFmrEF had LVEF measured: 24% had LVEF<40%, 43% maintained LVEF 40%-49% and 33% had LVEF>50%. While change in LVEF as continuous variable was not associated with better outcomes, those patients who evolved from HFmrEF to HFpEF did have a better outcome. Those who remained in the HFmrEF and HFrEF groups had higher all-cause mortality after adjustment for age, sex and baseline LVEF (HR 1.96 (95% CI 1.08 to 3.54, P=0.027) and HR 2.01 (95% CI 1.04 to 3.86, P=0.037), respectively). CONCLUSIONS: Patients with HFmrEF have a clinical profile in-between HFpEF and HFrEF, without differences in all-cause mortality and the composite end-point between the three groups. At 1 year, patients with HFmrEF exhibited the greatest variability in LVEF and this change was associated with survival.
- dc.format.mimetype application/pdf
- dc.identifier.citation Farré N, Lupon J, Roig E, Gonzalez-Costello J, Vila J0, Perez S. el al. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain). BMJ Open. 2017 Dec 21;7(12):e018719. DOI : 10.1136/bmjopen-2017-018719
- dc.identifier.doi http://dx.doi.org/10.1186/s13104-017-3024-8
- dc.identifier.issn 2044-6055
- dc.identifier.uri http://hdl.handle.net/10230/35622
- dc.language.iso eng
- dc.publisher BMJ Publishing Groupca
- dc.relation.ispartof BMJ Open. 2017 Dec 21;7(12):e018719
- dc.rights Copyright © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Echocardiography
- dc.subject.keyword Ejection fraction
- dc.subject.keyword Heart failure
- dc.subject.keyword Prognosis
- dc.subject.keyword Recovered
- dc.subject.other Infart de miocardi -- Prognosi
- dc.subject.other Ecocardiografia
- dc.subject.other Cor -- Malalties
- dc.title Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)ca
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion